Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
09/1996
09/19/1996CA2215016A1 Isolated nucleic acid molecules which are members of the mage-xp family and uses thereof
09/19/1996CA2214010A1 Recombinant viruses expressing lecithin-cholesterol acyltransferase, and uses thereof in gene therapy
09/18/1996EP0732397A2 Modified hepatocytes and uses therefor
09/18/1996EP0731839A1 Vector, viral protein, nucleotide sequence coding therefor and method for inhibiting immune recognition
09/18/1996EP0731809A1 Chirally enriched synthetic phosphonate oligomers
09/18/1996EP0731808A1 Nucleosides and oligonucleotides containing boron clusters
09/18/1996EP0731807A1 N-2 substituted purines
09/17/1996US5556763 Patterns of transcription factors and lymphocytes
09/12/1996WO1996027677A2 Method of purification of recombinant viral vectors containing a therapeutic gene
09/12/1996WO1996027672A1 Latency active herpes virus promoters and their use to treat neurological lesions
09/12/1996WO1996027664A2 Antisense transcript expressed in b lymphocytes and synthetic oligonucleotides useful to inhibit the activity thereof
09/12/1996WO1996027663A2 An antisense transcript associated to tumor cells having a t(14;18) translocation and oligodeoxynucleotides useful in the diagnosis and treatment of said tumor cells
09/12/1996WO1996027610A1 Nucleotide and protein sequences of vertebrate serrate genes and methods based thereon
09/12/1996WO1996027606A1 Improved process for the synthesis of 2'-o-substituted pyrimidines and oligomeric compounds therefrom
09/12/1996WO1996027603A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/12/1996WO1996027393A1 A dry powder formulation for gene therapy
09/12/1996WO1996027392A1 Antigen presenting system and methods for activation of t-cells
09/12/1996WO1996021733A3 Transfert of dna in cells with the view to correcting the adrenoleucodystrophy
09/12/1996CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders
09/11/1996EP0730657A1 Composition for the in vivo production of therapeutic products
09/11/1996EP0730648A1 HUMAN MUTATOR GENE hMSH2 AND HEREDITARY NON POLYPOSIS COLORECTAL CANCER
09/11/1996EP0730606A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
09/11/1996EP0730568A1 Amphiphilic derivatives of piperazine
09/11/1996EP0730405A1 Amphiphilic derivatives of guanidine
09/11/1996EP0730404A1 Amphiphilic imidazolinium derivatives
09/11/1996EP0528903B1 Methods of preventing viral replication
09/10/1996US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences
09/06/1996WO1996027128A2 Hiv determinants required for in vivo replication
09/06/1996WO1996027020A1 Atherosclerosis gene therapy using monocyte line hdl production
09/06/1996WO1996027009A1 Human amine transporter
09/06/1996WO1996027008A2 Agent for treating tumours and other hyperplasia
09/06/1996WO1996027006A2 Human vegf-specific antisense oligonucleotides
09/06/1996WO1996026745A1 Biosynthetic virus vectors for gene therapy
09/06/1996WO1996026743A1 Radiation enhanced gene therapy for treatment of tumors
09/06/1996WO1996026742A1 Gene transfer-mediated angiogenesis therapy
09/06/1996WO1996026733A1 Codominance-mediated toxins
09/06/1996WO1996021470A3 Compositions of nucleic acid and viscosity-increasing polymers for use in gene therapy
09/06/1996WO1996021035A3 Retroviral delivery of full length factor VIII
09/06/1996WO1996021015A3 Combination gene delivery vehicles
09/06/1996WO1996021007A3 Bacteriophage-mediated gene transfer systems capable of transfecting eukaryotic cells
09/06/1996WO1996020954A3 Functionally active domains of signal transducer and activators of transcription (STAT) proteins
09/06/1996WO1996020277A3 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen
09/06/1996WO1996020219A3 Murine monoclonal anti-idiotype antibody 3h1
09/06/1996WO1996019965A3 Engraftment of hematopoietic cells from a primate donor to a primate recipient
09/06/1996WO1996018372A3 Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
09/06/1996CA2188575A1 Gene transfer-mediated angiogenesis therapy
09/04/1996EP0729516A1 Recombinant adenoviruses for gene therapy in cancers
09/04/1996EP0729515A1 Transcriptional regulatory sequence of carcinoembryonic antigen for expression targeting
09/04/1996EP0729511A1 Compositions and methods for utilizing conditionally lethal genes
09/04/1996EP0729506A1 Myocardial grafts and cellular compositions useful for same
09/04/1996EP0729474A1 Synthetic oligomers having chirally pure phosphonate internucleosidyl linkages mixed with non-phosphonate internucleosidyl linkages
09/04/1996EP0729300A1 Novel fas protein and methods of use thereof
09/04/1996EP0630384A4 Methods and compounds for prevention of graft rejection.
09/04/1996EP0560932B1 Methods and compositions for the suppression of neu mediated transformation
09/04/1996EP0506884B1 Method of delivering molecules into eukaryotic cells
09/04/1996EP0420911B1 Gene therapy using gene fusions for genetic or acquired disorders
09/03/1996US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III)
09/03/1996US5552391 Chemically-defined non-polymeric valency platform molecules and conjugates thereof
09/03/1996US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy
09/03/1996US5552277 Genetic diagnosis of prostate cancer
09/03/1996US5552157 Quaternary ammonium lipids
09/03/1996CA1338570C Endowing cells with antibody specificity
08/1996
08/29/1996WO1996026286A1 Methods and compositions for gene therapy for the treatment of defects in lipoprotein metabolism
08/29/1996WO1996026285A2 Methods and compositions for administering gene therapy vectors
08/29/1996WO1996026284A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/29/1996WO1996026281A1 Chimeric adenoviral fiber protein and methods of using same
08/29/1996WO1996026280A1 NOVEL CYSTEINE PROTEASE RELATED TO INTERLEUKIN-1β CONVERTING ENZYME
08/29/1996WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996WO1996026272A1 Prostate-specific membrane antigen and uses thereof
08/29/1996WO1996026271A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
08/29/1996WO1996026270A1 Dna molecules, preparation thereof and use thereof in gene therapy
08/29/1996WO1996026267A1 Viral preparations, vectors, immunogens, and vaccines
08/29/1996WO1996026265A1 Redirection of cellular immunity by protein-tyrosine kinase chimeras
08/29/1996WO1996026179A1 Novel cationic lipids and the use thereof
08/29/1996WO1996025953A1 Redirection of cellular immunity by receptor chimeras
08/29/1996WO1996025947A2 Induction of e-selectin for targetting therapeutic agents
08/29/1996WO1996025945A1 ISOFORMS OF HUMAN INTERLEUKIN-1β CONVERTING ENZYME AND METHODS OF USING THE SAME
08/29/1996WO1996025942A1 Cochleate phospholipids in drug delivery
08/29/1996WO1996025941A1 Modulators of regulatory proteins
08/29/1996WO1996019580A3 Telomerase protein component
08/29/1996WO1996018737A3 Vectors and viruses for use in gene therapy
08/29/1996WO1996017869A3 Interleukin-6 (il-6) antagonists
08/29/1996WO1996014412A3 cDNA ENCODING A BMP TYPE II RECEPTOR
08/29/1996DE19539130A1 Mittel zur Therapie von Tumoren und anderen Hyperplasien Means for the therapy of tumors and other hyperplasias
08/29/1996CA2213610A1 Ingap protein involved in pancreatic islet neogenesis
08/29/1996CA2213484A1 Modulators of regulatory proteins
08/29/1996CA2213451A1 Generation of human cytotoxic t-cells specific for carcinoma self-associated antigens and uses thereof
08/29/1996CA2213439A1 Methods and compositions for administering gene therapy vectors
08/29/1996CA2213417A1 Novel cationic lipids and the use thereof
08/29/1996CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof
08/29/1996CA2212846A1 Prostate-specific membrane antigen and uses thereof
08/29/1996CA2211743A1 Viral preparations, vectors, immunogens, and vaccines
08/29/1996CA2211541A1 Isoforms of human interleukin-1.beta. converting enzyme and methods of using the same
08/29/1996CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins
08/28/1996EP0728209A1 Endothelin-converting enzyme
08/28/1996EP0728206A1 Alteration of sequence of a target molecule
08/28/1996EP0728202A1 Episomal expression vector for human gene therapy
08/28/1996EP0728200A1 Haemophilus transferrin receptor genes
08/28/1996EP0728194A1 $i(IN SITU) MODIFICATION AND MANIPULATION OF STEM CELLS OF THE CENTRAL NERVOUS SYSTEM
08/28/1996CN1129737A Modified protein for gene transfer and process for producing the same
1 ... 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 ... 870